Maxim Group
http://www.maximgrp.com/Maxim Group is a financial services firm that provides investment banking, asset management, research, and sales & trading to a diverse range of corporate clients, institutional investors and high net worth individuals.
The firm’s research division uses fundamental research and a “bottom up” approach to making investment recommendations. Maxim’s research analysts focus on under-covered, small- to mid-cap names in a variety of sectors including healthcare, technology, retail and others.
View Older Stories View More Recent Stories
-
Viking Therapeutics Announces $4.3 Million Registered Direct Offering
-
Maxim Group Upgrades Cheesecake Factory (CAKE) to Buy
-
Maxim Group Reiterates Buy on Omeros (OMER) Following Announced Therapy Designation for OMS721
-
Maxim Group Reiterates Buy Rating & $4 PT on Trovagene (TROV); 'AstraZeneca (AZN) On Board to Use Trovera'
-
MagneGas (MNGA) Receives $25M from Convertible Preferred Financing
-
MagneGas Announces $25 Million Convertible Preferred Financing
-
Maxim Group Downgrades SciClone Pharmaceuticals (SCLN) to Hold
-
Inolife Technologies Announces Non-Brokered Private Placement
-
Maxim Group Starts Tecogen (TGEN) at Buy
-
Maxim Group Starts Sensus Healthcare (SRTS) at Buy
-
Sonoma Pharmaceuticals (SNOA) PT Raised to $10 at Maxim Group Following 4Q
-
Complimentary Transcript Available for Product Tanker Webinar
-
Maxim Group Upgrades bluebird bio (BLUE) to Buy Ahead of ASCO Presentation
-
Inolife Technologies Inc. (OTC: INOL) Engages Investment Banking Firm the Maxim Group LLC
-
Provision Holding to Present at Maxim Group Consumer Technology Conference
-
Maxim Group LLC Appoints Four Managing Directors in Equity Research Division
-
Maxim Group Upgrades Potbelly Corp (PBPB) to Buy
-
Reminder: Product Tanker Sector Webinar
-
National Energy Services Reunited Corp. Announces Closing of Partial Over-Allotment Exercise in Connection with its Initial Public Offering
-
National Energy Services Reunited Corp. Announces Closing of Partial Over-Allotment Exercise in Connection with its Initial Public Offering
-
UPDATE - Product Tanker Sector Webinar
-
Product Tanker Sector Webinar
-
UPDATE: Inovio Pharmaceuticals (INO) PT Raised to $12 at Maxim Group; 'A Step Closer to HIV Vaccine, PENNVAX-GP Demonstrates High Immune Response Rates'
-
Maxim Group Announces Strategic Promotions in Healthcare Research
-
New Age Beverages Corp (NBEV) PT Raised to $7.50 at Maxim Group
-
UPDATE: Maxim Group Upgrades Buffalo Wild Wings, Inc. (BWLD) to Buy, PT to $180; 'Potential Upside Offsets Potential Risk'
-
2017 Marcum MicroCap Conference Panels: Topics for All Segments of the Small Cap Equities Market
-
Maxim Group Upgrades BioLineRx (BLRX) to Buy
-
National Energy Services Reunited Corp. Completes $210,000,000 Initial Public Offering
-
National Energy Services Reunited Corp. Completes $210,000,000 Initial Public Offering
-
SITO Mobile Issues Open Letter to Stockholders
-
Coherus Biosciences (CHRS) PT Raised to $44 at Maxim Group; 'David Delivers a Blow to Goliath - Humira Patent '135 Falls'
-
Maxim Group Downgrades Mateon Therapeutics (MATN) to Hold
-
New Age Beverages Corporation Announces Investor Conference Call to Discuss First Quarter 2017 Results
-
National Energy Services Reunited Corp. Announces Pricing of $210,000,000 Initial Public Offering
-
National Energy Services Reunited Corp. Announces Pricing of $210,000,000 Initial Public Offering
-
Maxim Group Downgrades Syneron Medical (ELOS) to Hold
-
Red Robin Gourmet Burgers (RRGB) PT Raised to $75 at Maxim Group Ahead of 1Q Release
-
Maxim Group Starts Control4 Corporation (CTRL) at Hold
-
Gladstone Investment (GAIN) Prices 2.1M Common Stock Offering at $9.38/Share
-
Gladstone Investment Corporation Prices Common Stock Offering
-
Gladstone Investment (GAIN) Plans Common Stock Offering
-
Gladstone Investment Corporation Announces Common Stock Offering
-
Keryx Biopharma (KERX): Expanding Model And Raising PT - Maxim
-
Walker Innovation Announces First Quarter 2017 Results
-
National Beverage (FIZZ) 'Rebukes' Maxim Report
-
National Beverage Corp. Rebukes Maxim Report
-
Pre-Open Movers 05/04: (TLRD) (CNAT) (FIT) Higher; (BPMX) (SRC) (FIZ) Lower (more...)
-
Immune Pharma (IMNP) Announces Private Placement of up to $3.4M of Convertible Debentures
-
Immune Pharmaceuticals Announces Private Placement of up to $3.4 Million


